Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of WT1 platelets require individualized development of treatment regimens for reducing the incidence of the disease, typically including drug therapy, rehabilitation, regular follow-up, and multidimensional management.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumor diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to changes in disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the prevalence of leukemia associated with WT1 related platelets.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.